Cash Flow from Financial Activities: The net amount of cash transactions used in funding activities.
Aptevo Therapeutics Inc. (APVO) had Cash Flow from Financial Activities of $0.87M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-6.79M |
|
-- |
|
-- |
|
$6.84M |
|
$-6.84M |
|
$0.14M |
|
$-6.70M |
|
$-6.70M |
|
$-6.70M |
|
$-6.70M |
|
$-6.70M |
|
$-6.70M |
|
$-6.84M |
|
$-6.80M |
|
1.06M |
|
1.06M |
|
$-6.41 |
|
$-6.41 |
|
| Balance Sheet Financials | |
$15.98M |
|
$0.27M |
|
$3.92M |
|
$19.90M |
|
$4.76M |
|
-- |
|
$3.53M |
|
$8.29M |
|
$11.61M |
|
$11.61M |
|
$11.61M |
|
1.20M |
|
| Cash Flow Statement Financials | |
$-7.96M |
|
-- |
|
|
Cash Flow from Financial Activities |
$0.87M |
$21.62M |
|
$14.53M |
|
$-7.09M |
|
$0.06M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.36 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-7.96M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-57.67% |
|
-57.67% |
|
-33.65% |
|
-57.67% |
|
$9.64 |
|
$-7.51 |
|
$-7.51 |
|